# ReCyte Therapeutics, Inc. — Form D

ReCyte Therapeutics, Inc. of ALAMEDA, CA, a company, filed a Form D exempt-offering notice with the SEC on 2011-01-14. The offering totals $2.5M, of which $2.5M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2011-01-14
- Form: D
- Accession: 0001462573-11-000001
- Industry: Biotechnology
- Exemptions: 06, 46
- Total offering: $2.5M
- Amount sold: $2.5M
- Investors: 2
- Date of first sale: 2010-12-30
- Security types: equity
- Revenue range: $1 - $1,000,000
- SEC file number: 021-153749

## Issuer

- Name: ReCyte Therapeutics, Inc.
- CIK: 0001509728
- Entity type: Corporation
- Jurisdiction: CALIFORNIA
- Incorporated: 2007
- Address: 1301 HARBOR BAY PARKWAY, SUITE 100, ALAMEDA, CA, 94502
- Phone: (510) 521-3390

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| Alfred D Kingsley | Director | Irvine, CA |
| Robert D Peabody | Director | Alameda, CA |
| Michael D West | Director | Menlo Park, CA |
| Alfred D Kingsley | Executive Officer | Irvine, CA |
| Robert D Peabody | Executive Officer | Alameda, CA |
| Judith D Segall | Executive Officer | Alameda, CA |
| Michael D West | Executive Officer | Menlo Park, CA |

## More

- [CIK 1509728 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1509728&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001462573-11-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.